Recombinant SARS-CoV-2 S1 subunit protein RBD, double mutant L452R/E484Q with C-terminal His-tag, derived from the transfected human HEK293 cells.
Loading...
Loading...
Loading...
Loading...
Recombinant SARS-CoV-2 S1 Subunit Protein RBD, double mutant L452R/E484Q
| Size | 100 µg, 500 µg |
| Estimated Lead Time | 1-2 business days |
| Species | SARS-CoV-2 |
| Accession Number | QHD43416 |
| Gene Symbols | S |
| Protein Name / Synonyms | Spike protein, S Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD) |
| Expressed Region | Arg319-Phe541. L452R/E484Q double mutant: amino acid Leu (L) at 452 position was mutated to Arg (R); amino acid Glu (E) at 484 position was mutated to Gln (Q). |
| Expression System | HEK293 cells |
| Tag | C-terminal his-tag |
| Purity | >95 % |
| Purity Determined By | SDS-PAGE under reducing conditions and visualized by Coomassie blue staining |
| Molecular Weight (kDa) | Recombinant protein product has a calculated molecular mass of ∼25 kDa. Due to the abundant glycosylation, it migrates as approximately 30 kDa protein bands in SDS-PAGE under DTT, beta-mercaptoethanol reducing conditions. After deglycosylation under native and denature conditions, the protein presented as one reduced ∼25 kDa band. See deglycosylation analysis image below. |
| Format | Liquid |
| Formulation | Supplied as a 0.2 µm filtered solution in PBS (pH 7.4) |
| Concentration (lot specific) | Lot specific (see the label on the vial), determined by BCA protein assay |
| Endotoxin Level | < 0.5 EU per µg of the protein as determined by the LAL method |
| Research Area | Infectious Disease, COVID-19 |
| Shipping Type | Blue ice |
| Storage | -20°C |


Your cart is empty.
Recombinant SARS-CoV-2 S1 Subunit Protein RBD, double mutant L452R/E484Q